Form4insider filings, from the source

SEC Form 4 · accession 0001171843-15-000644

Anika Therapeutics, Inc. · ANIK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Charles H Sherwood
Officer — President and CEO · Director
Period of report
Feb 3, 2015
Accepted (ET)
Feb 5, 2015 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 3, 2015A13,500$0.00A191,455D
Common StockF2Feb 4, 2015A50,000$8.71A241,455D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F3$39.69Feb 3, 2015A34,200A—Feb 3, 2025Common Stock13,70034,200D
Stock Option (Right to Buy)F5,F4,F6$32.02Feb 3, 2015A16,600A—Jan 27, 2024Common Stock16,60016,600D
Stock Option (Right to Buy)F2$8.71Feb 4, 2015M50,000D—Feb 10, 2015Common Stock50,0000D

Explanation of responses